Skip to content

Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.

Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005705
Enrollment
17
Registered
2013-12-09
Start date
2013-12-31
Completion date
2016-06-30
Last updated
2016-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Bleeding

Brief summary

Patients presenting to the emergency room with upper gastrointestinal bleeding and a Glasgow Blatchford score of zero will be randomly assigned to further care in the inpatient vs. outpatient setting. The hypothesis of this study is that patients who are managed as outpatients will require interventions at a rate not higher than those managed as inpatients and will have lower direct healthcare costs.

Interventions

OTHEROutpatient Management of Low-risk Patients

* Labs will be obtained within 2-3 days of discharge from ED * Clinic visit will be scheduled within 3 days of discharge from ED * EGD will be scheduled within 7 days of discharge from ED * Phone follow-up at day 7 and 30

OTHERInpatient Management of Low-risk Patients

* Labs will be obtained on day of discharge or day 2-3 * EGD will be performed in the hospital * Phone follow-up at day 7 and 30

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Blood Urea Nitrogen \< 18.2 mg/dl 2. Hemoglobin ≥ 13.0 g/dl for men and ≥ 12.0 g/dl for women 3. Systolic blood pressure ≥ 110 mm Hg 4. Heart rate \< 100 beats/min

Exclusion criteria

1. Inability to obtain informed consent 2. Pregnancy 3. History of liver disease 4. History of heart failure 5. Syncope that is temporally related to ongoing bleeding 6. Melena 7. Contraindication to proton pump inhibitor use 8. Other conditions that necessitate inpatient evaluation. 9. Inpatients with new onset of GI bleeding

Design outcomes

Primary

MeasureTime frame
The number of patients requiring intervention for UGIB (endoscopic therapy, blood transfusion, surgery, interventional radiology)Within 7 days of the index presentation to the emergency room

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026